toh

Jill Hamer-Wilson has dedicated her life to advocating for patient partnership in lung cancer research, with the hope of helping others identify the early signs of lung cancer.

In September of 2013, Jill Hamer-Wilson caught something many of us tend to catch this time of year – a cold. While the cold eventually went away, a cough remained, and lingered for quite some time. Little did Jill know that this was an early sign of lung cancer.

She was diagnosed with lung cancer just a few months later, in December of that year. Jill had never smoked. She was very active. In fact, she had just taken part in the Army Run that fall. To say this news came as a shock would be an understatement.

While a lung cancer diagnosis can cause a range of reactions from anyone, for Jill, it fuelled a new purpose. Throughout her years of treatment plans, different forms of cancer therapy and medication changes, Jill became an advocate for lung cancer research and awareness.

“The area of lung cancer research is exploding,” said Jill. “While previously, there was not much research done on this form of cancer, the list of studies and clinical trials continues to grow. As someone living with lung cancer, I’m comforted and excited to know that this area of research is growing.”

What makes lung cancer research so important? Aside from the fact that research can help uncover new forms of treatment, more research can help people understand the early signs of lung cancer, which can give clinicians a better chance to treat it.

“There are many things that more research helps us do, but helping people recognize the early signs of lung cancer could be among the most important. That is how we catch it early, treat it early and ultimately help people live longer.”

“Unfortunately in 2020, half of all lung cancers are diagnosed at an advanced stage, with no realistic chance of cure. Therefore early detection is the key to effective treatment for any kind of cancer, but especially cancer of the lungs,” said Dr. Paul Wheatley-Price, medical oncologist at The Ottawa Hospital and president of Lung Cancer Canada.

“The more awareness we can create about the early signs of lung cancer, the better chance we have of diagnosing and treating it early, which will ultimately lead to better outcomes for patients,” he continued. “Further, The Ottawa Hospital is one of the leading centres in the province in implementing a lung cancer screening program for early detection, which we hope to see available across the country.”

What do we know now?

According to the Canadian Cancer Society, the most common symptoms of lung cancer are:

• a cough that gets worse or doesn’t go away
• shortness of breath
• wheezing
• chest pain that is always felt and gets worse with deep breathing or coughing
• blood in mucus coughed up from the lungs
• chest infections like bronchitis or pneumonia that don’t get better or keep coming back
• weight loss
• fatigue
• hoarseness or other voice changes
• difficulty swallowing
• collapsed lung
• larger than normal lymph nodes in the neck or above the collarbone
• buildup of fluid around the lungs (pleural effusion)
• bone pain
• headache
• weakness

However, very few people think much of a cough before it gets really bad. So how do you know when to go to the hospital, or talk to your doctor? That is where further research on early detection can make all the difference.

“For now, if you have a persistent cough lasting for more than three weeks, make an appointment to see your doctor,” said Dr. Wheatley-Price.

Patient advocate in cancer research

For Jill, the need for early detection is part of the reason she has become so involved in lung cancer research. She is now involved in a number of cancer-focused organizations, including the American Association of Cancer Research, the Canadian Cancer Society, Lung Cancer Canada, The Ottawa Hospital, the Canadian Cancer Trials Group and the Supportive Training for Advocates on Research in Science (STARS) program, which works towards strengthening the patient voice in cancer research.

The STARS program focuses on training people to become lung cancer research advocates, helping them be better equipped to represent the patient voice in the research process. This is increasingly important as researchers are now discovering and embracing the fact that including the patient voice in the research process improves the research and therefore outcomes.

Having someone to talk to who has been through cancer treatment before can be a welcome source of support through the process. Mentorship also helps patients learn more about how to advocate for themselves and others in their position.

“I didn’t really know where to start, I just knew I wanted to get more involved,” said Jill. “Getting more involved has helped me learn more about what it means to be an advocate, and how I can share that knowledge with others.”

What does the future hold?

In the end, Jill just wants what any mother would want: to watch her kids grow up. Her oldest is heading off to university this year, something she proudly shares whenever she can, as any mother would. She is focused on the things many of us take for granted, like enjoying family time. But she is by no means slowing down.

Jill’s work as an advocate for patient partnership in cancer research keeps her very busy. In the last year alone, she has been to Atlanta, Barcelona and Washington! No matter where she goes, she is driven by one goal: to help research get closer to early detection of lung cancer.

“There are many things that more research helps us do, but helping people recognize the early signs of lung cancer could be among the most important. That is how we catch it early, improve treatment and ultimately help people live longer.”

If you want to learn more about Jill’s journey, or find out how you can get more involved in cancer research and advocacy, follow her on Twitter (@JillHW) or her blog Through the Valley.

You might also like…

What’s the difference between an optician, optometrist, orthoptist and ophthalmologist?

“Do I need to see an optician, optometrist, orthoptist or ophthalmologist?” We asked Ophthalmologist Dr. Annick Fournier to break down each role so you will know who to consult for your specific eye care needs.

Education, Population Health

Understanding rabies: Risks, vaccination and what to do after a bite

Although rare in Canada, rabies is almost always fatal once symptoms appear. Infectious diseases expert Dr. Michaeline McGuinty shares how rabies is spread, when to get vaccinated and what to do after a bite.

Education, Population Health

Do you have a surgery coming up? Here are five “prehab” tips to help you recover faster

You’ve probably heard about rehabilitation, but what about “prehabilitation”? Prehab is all about getting your body and mind in top shape before surgery so you can enjoy a smoother, quicker recovery. Discover five essential prehab strategies from researcher Dr. Daniel McIsaac.

Education, Rehabilitation, Research

“My story doesn’t have to be your story”: New screening test better at preventing cervical cancer

“I went from being a 32-year-old new mom to a cancer patient with an incurable diagnosis.” Alicia’s journey underscores the critical role of HPV testing in preventing cervical cancer. Discover how the new HPV test can save lives and find out how to book your cervical screening appointment with our “Superscreener.”

Cancer, Population Health, Screening

Sign language interpretation services at The Ottawa Hospital: 5 FAQs

Do you require a sign language interpreter when you come to The Ottawa Hospital? For patients who are Deaf or hard of hearing, we provide both American Sign Language (ASL) and Langue des Signes Québécoise (LSQ) interpretation services at no cost. Before your next appointment with us, find out everything you need to know.

Patients as Partners, Population Health

By thinking differently, this research team is improving the lives of people with cancer

Taking a different approach to clinical trials, the REthinking Clinical Trials (REaCT) program aims to answer some of the most important and practical questions that affect both patients with cancer and our health-care system. Find out what sets REaCT apart and makes the program so special to participants like Beth.

Cancer, Clinical Trials, Research